High prices have been attributed to monopolies given to manufacturers by the government and a lack of ability for organizations to negotiate prices.[20] New drug development costs continue to rise as well. Despite the enormous advances in science and technology, the number of new blockbuster drugs approved per billion dollars spent has halved every 9 years since 1950.[21]
